Quantitative assessment of HBsAg in the process of treatment of chronic hepatitis В with pegilated interferon alpha-2a (Pegasis): a new tool for the prediction of effective treatment
- Authors: Nikitin IG1, Baykova IE1, Gogova LM1, Volynkina VM1, Nikitin I1, Baikova I1, Gogova L1, Volynkinа V1
-
Affiliations:
- Issue: No 2 (2010)
- Pages: 12-18
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278200
- ID: 278200
Cite item
Full Text
Abstract
About the authors
I G Nikitin
I E Baykova
L M Gogova
V M Volynkina
I Nikitin
I Baikova
L Gogova
V Volynkinа
References
- Koff R. Chronic viral hepatitis. Humana Press, New Jersey. 2006;340.
- Feldmann M, Friedmann L, Sleisinger M. Gastrointestinal and Liver Disease. 9th Edition. Saunders 2009;1278-334.
- Cheung RC. Epidemiology of hepatitis B virus infection in Asian and European population. J Hepatology 2000;45:740-47.
- Tradati F, Colombo M. Prospective multicenter study of hepatocellular carcinoma in hemophiliacs. Blood 1998;91:1173-77.
- Шахгильдян И. В. Эпидемиологические аспекты хронических вирусных гепатитов/ Материалы XIV Российской конференции «Гепатология сегодня» // Российский журнал гастроэнтерологии, гепатологии и колопроктологии. 2009. № 42. С. 24.
- Chaw L. The modern aspects of antiviral treatment the patients with chronic viral hepatitis B. Hepatology 2008;34:1234-39.
- Cooksley W.G. Pegylated interferon - alfa2a ("Pegasys") in patients with chronic viral hepatitis B. Hepatology 2002;36:A374.
- Hadziyannis S, Lau GKK, Marcellin P, et al. Sustained HBsAg seroconversion in patients with chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS®). J Hepatol 2005;42(2):178 (Abstract).
- Moucari R. et al. Hepatitis B virus surface antigen levels during and after pegylated interferon - alfa 2a treatment might be predictors of sustained viral response. Hepatology 2009;49:1151.
- Brunetto M.R. et al. Predicting Responce to hepatitis B virus therapy. Hepatology 2009;49:1141.
- Marcellin P. Early HBsAg Decline Predicts Sustained Response to Pegylated Interferon. Hepatology 2009;49:1162.
- http://www.pharmateca.ru/cgi-bin/statyi.pl?sid=2500&mid=1085056570&magid=186